BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 25464904)

  • 1. MicroRNAs as therapeutic targets in atherosclerosis.
    Loyer X; Mallat Z; Boulanger CM; Tedgui A
    Expert Opin Ther Targets; 2015 Apr; 19(4):489-96. PubMed ID: 25464904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs and atherosclerosis: new actors for an old movie.
    Santovito D; Mezzetti A; Cipollone F
    Nutr Metab Cardiovasc Dis; 2012 Nov; 22(11):937-43. PubMed ID: 22748605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in atherosclerosis.
    Hosin AA; Prasad A; Viiri LE; Davies AH; Shalhoub J
    J Vasc Res; 2014; 51(5):338-49. PubMed ID: 25500818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice.
    Loyer X; Potteaux S; Vion AC; Guérin CL; Boulkroun S; Rautou PE; Ramkhelawon B; Esposito B; Dalloz M; Paul JL; Julia P; Maccario J; Boulanger CM; Mallat Z; Tedgui A
    Circ Res; 2014 Jan; 114(3):434-43. PubMed ID: 24255059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional Nanoparticles Facilitate Molecular Targeting and miRNA Delivery to Inhibit Atherosclerosis in ApoE(-/-) Mice.
    Kheirolomoom A; Kim CW; Seo JW; Kumar S; Son DJ; Gagnon MK; Ingham ES; Ferrara KW; Jo H
    ACS Nano; 2015 Sep; 9(9):8885-97. PubMed ID: 26308181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNAs in atherosclerotic plaque initiation, progression, and rupture.
    Andreou I; Sun X; Stone PH; Edelman ER; Feinberg MW
    Trends Mol Med; 2015 May; 21(5):307-18. PubMed ID: 25771097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis?
    Wei Y; Nazari-Jahantigh M; Neth P; Weber C; Schober A
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):449-54. PubMed ID: 23324496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-155 in the pathogenesis of atherosclerosis: a conflicting role?
    Ma X; Ma C; Zheng X
    Heart Lung Circ; 2013 Oct; 22(10):811-8. PubMed ID: 23827206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of microRNAs in coronary artery disease: From pathophysiology to diagnosis and treatment.
    Economou EK; Oikonomou E; Siasos G; Papageorgiou N; Tsalamandris S; Mourouzis K; Papaioanou S; Tousoulis D
    Atherosclerosis; 2015 Aug; 241(2):624-33. PubMed ID: 26117399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From miRNA regulation to miRNA-TF co-regulation: computational approaches and challenges.
    Le TD; Liu L; Zhang J; Liu B; Li J
    Brief Bioinform; 2015 May; 16(3):475-96. PubMed ID: 25016381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The microRNA-342-5p fosters inflammatory macrophage activation through an Akt1- and microRNA-155-dependent pathway during atherosclerosis.
    Wei Y; Nazari-Jahantigh M; Chan L; Zhu M; Heyll K; Corbalán-Campos J; Hartmann P; Thiemann A; Weber C; Schober A
    Circulation; 2013 Apr; 127(15):1609-19. PubMed ID: 23513069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atheroprotective mechanisms of shear stress-regulated microRNAs.
    Boon RA; Hergenreider E; Dimmeler S
    Thromb Haemost; 2012 Oct; 108(4):616-20. PubMed ID: 22955103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs and atherosclerosis.
    Madrigal-Matute J; Rotllan N; Aranda JF; Fernández-Hernando C
    Curr Atheroscler Rep; 2013 May; 15(5):322. PubMed ID: 23512606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mir-221/222 are promising targets for innovative anticancer therapy.
    Di Martino MT; Rossi M; Caracciolo D; Gullà A; Tagliaferri P; Tassone P
    Expert Opin Ther Targets; 2016 Sep; 20(9):1099-108. PubMed ID: 26959615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of miRNA technology for atherosclerosis.
    Toba H; Cortez D; Lindsey ML; Chilton RJ
    Curr Atheroscler Rep; 2014 Feb; 16(2):386. PubMed ID: 24395388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNAs in Cerebrovascular Disease.
    Volný O; Kašičková L; Coufalová D; Cimflová P; Novák J
    Adv Exp Med Biol; 2015; 888():155-95. PubMed ID: 26663183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncoding RNAs in vascular inflammation and atherosclerosis: recent advances toward therapeutic applications.
    Cochain C; Zernecke A
    Curr Opin Lipidol; 2014 Oct; 25(5):380-6. PubMed ID: 25051497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs and the response to injury in atherosclerosis.
    Natarelli L; Schober A
    Hamostaseologie; 2015; 35(2):142-50. PubMed ID: 25612846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The magic and mystery of microRNA-27 in atherosclerosis.
    Chen WJ; Yin K; Zhao GJ; Fu YC; Tang CK
    Atherosclerosis; 2012 Jun; 222(2):314-23. PubMed ID: 22307089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease.
    Kaucsár T; Rácz Z; Hamar P
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1390-401. PubMed ID: 20940025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.